EnteroLab was founded in 2001 by Dr. Kenneth Fine M.D. Dr. Fine is an internationally acclaimed academic medical doctor, certified in internal medicine and gastroenterology with a profound professional experience for over 25 years.
EnteroLab has developed a unique screening test for gluten sensitivity, as well as for many other antigenic food sensitivities, that is more sensitive and specific than tests in current use (U.S. and International patents issued). Our method utilizes stool rather than blood as the testing substrate; the rationale of using stool rather than blood for testing for food sensitivity is that immunologic reactions to proteins in the diet that cause these reactions are centered within the intestinal tract and not in the blood. We believe that our new tests can improve the health of millions of people worldwide.
To-date EnteroLab has served over 100,000 patients and is referred by a network of over 1,500 health practitioners. The company is based in Dallas, Texas.
EnteroLab was conceived because of the public health implications of the scientific discoveries of Kenneth Fine, M.D., a professor, intestinal researcher, and publisher of scientific journal articles for over 18 years. Dr. Fine is determined to bring the benefits of this research to those who need it most: people suffering ill-health effects, particularly intestinal illnesses, as the result of gluten sensitivity, microscopic colitis, yeast sensitivity, and the other causes of intestinal disease and dysfunction. By utilizing the power of the internet and the public’s free access to it, the long delay associated with dissemination of new information through the medical ranks to patients (usually 10-15 years) can be bypassed. People can benefit today!
The Mission of EnteroLab is to improve the intestinal and overall health of men and women through expert diagnostic testing and analysis of intestinal specimens